278 related articles for article (PubMed ID: 15385955)
1. Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.
Tanaka N; Nakanishi M; Kusakabe Y; Goto Y; Kitade Y; Nakamura KT
EMBO J; 2004 Oct; 23(20):3929-38. PubMed ID: 15385955
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for recognition of 2',5'-linked oligoadenylates by the N-terminal ankyrin repeat domain of human ribonuclease L.
Tanaka N; Nakanishi M; Kusakabe Y; Goto Y; Kitade Y; Nakamura KT
Nucleic Acids Symp Ser (Oxf); 2005; (49):323-4. PubMed ID: 17150764
[TBL] [Abstract][Full Text] [Related]
3. 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L.
Nakanishi M; Goto Y; Kitade Y
Proteins; 2005 Jul; 60(1):131-8. PubMed ID: 15849753
[TBL] [Abstract][Full Text] [Related]
4. Innate immune messenger 2-5A tethers human RNase L into active high-order complexes.
Han Y; Whitney G; Donovan J; Korennykh A
Cell Rep; 2012 Oct; 2(4):902-13. PubMed ID: 23084743
[TBL] [Abstract][Full Text] [Related]
5. Dimeric structure of pseudokinase RNase L bound to 2-5A reveals a basis for interferon-induced antiviral activity.
Huang H; Zeqiraj E; Dong B; Jha BK; Duffy NM; Orlicky S; Thevakumaran N; Talukdar M; Pillon MC; Ceccarelli DF; Wan LC; Juang YC; Mao DY; Gaughan C; Brinton MA; Perelygin AA; Kourinov I; Guarné A; Silverman RH; Sicheri F
Mol Cell; 2014 Jan; 53(2):221-34. PubMed ID: 24462203
[TBL] [Abstract][Full Text] [Related]
6. Expression of interferon-inducible recombinant human RNase L causes RNA degradation and inhibition of cell growth in Escherichia coli.
Pandey M; Rath PC
Biochem Biophys Res Commun; 2004 Apr; 317(2):586-97. PubMed ID: 15063798
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of 2',5'-linked oligoadenylate binding determinant of human RNase L.
Nakanishi M; Tanaka N; Mizutani Y; Mochizuki M; Ueno Y; Nakamura KT; Kitade Y
J Biol Chem; 2005 Dec; 280(50):41694-9. PubMed ID: 16234235
[TBL] [Abstract][Full Text] [Related]
8. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
[TBL] [Abstract][Full Text] [Related]
9. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L.
Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291
[TBL] [Abstract][Full Text] [Related]
10. A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L.
Townsend HL; Jha BK; Han JQ; Maluf NK; Silverman RH; Barton DJ
RNA; 2008 Jun; 14(6):1026-36. PubMed ID: 18426919
[TBL] [Abstract][Full Text] [Related]
11. Recognition of 2',5'-linked oligoadenylates by human ribonuclease L: molecular dynamics study.
Maláč K; Barvík I
J Mol Model; 2014 Apr; 20(4):2123. PubMed ID: 24633766
[TBL] [Abstract][Full Text] [Related]
12. Full activation of RNaseL in animal cells requires binding of 2-5A within ankyrin repeats 6 to 9 of this interferon-inducible enzyme.
Díaz-Guerra M; Rivas C; Esteban M
J Interferon Cytokine Res; 1999 Feb; 19(2):113-9. PubMed ID: 10090396
[TBL] [Abstract][Full Text] [Related]
13. Structural changes of human RNase L upon homodimerization investigated by Raman spectroscopy.
Kříž M; Snášel J; Kopecký V; Páv O; Rosenberg I; Stěpánek J
Biochim Biophys Acta; 2012 Sep; 1824(9):1039-44. PubMed ID: 22691533
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 2-5As possessing base-modified adenosines and their activities to human recombinant RNase L.
Kitade Y; Tanida Y; Tuboi T; Yoshimura A; Nakanishi M; Yatome C
Nucleic Acids Symp Ser; 2000; (44):29-30. PubMed ID: 12903252
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for 2'-5'-oligoadenylate binding and enzyme activity of a viral RNase L antagonist.
Ogden KM; Hu L; Jha BK; Sankaran B; Weiss SR; Silverman RH; Patton JT; Prasad BV
J Virol; 2015 Jul; 89(13):6633-45. PubMed ID: 25878106
[TBL] [Abstract][Full Text] [Related]
16. A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5' oligoadenylates.
Thakur CS; Xu Z; Wang Z; Novince Z; Silverman RH
Methods Mol Med; 2005; 116():103-13. PubMed ID: 16000857
[TBL] [Abstract][Full Text] [Related]
17. RNase L dimerization in a mammalian two-hybrid system in response to 2',5'-oligoadenylates.
Naik S; Paranjape JM; Silverman RH
Nucleic Acids Res; 1998 Mar; 26(6):1522-7. PubMed ID: 9490801
[TBL] [Abstract][Full Text] [Related]
18. The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.
Ibsen MS; Gad HH; Thavachelvam K; Boesen T; Desprès P; Hartmann R
J Virol; 2014 Dec; 88(24):14222-31. PubMed ID: 25275129
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insights into RNase L through use of an MDMX-derived multi-functional protein domain.
Garvie CW; Vasanthavada K; Xiang Q
Biochim Biophys Acta; 2013 Aug; 1834(8):1562-71. PubMed ID: 23608948
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on the biological properties of 2',5'-oligoadenylate derivatives with purified human RNase L expressed in E. coli.
Yoshimura A; Nakanishi M; Yatome C; Kitade Y
J Biochem; 2002 Oct; 132(4):643-8. PubMed ID: 12359081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
